GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC)

Symbol: IPSC on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$453,899	456,115	+10,806	+2.4%	$1.00	Q4 2025
30 Sep 2025	0%	+0%	$221,845	445,309	+65,032	+17%	$0.50	Q3 2025
30 Jun 2025	0%	-0%	$212,545	380,277	-589,983	-61%	$0.56	Q2 2025
31 Mar 2025	0%	-0%	$461,931	970,260	-21,335		$0.48	Q1 2025
31 Dec 2024	0%	+0%	$1,001,697	991,595	+23,413	+2.4%	$1.01	Q4 2024
30 Sep 2024	0%	+0%	$1,655,846	968,182	+32,614	+3.5%	$1.71	Q3 2024
30 Jun 2024	0%	+0%	$2,385,845	935,568	+424,977	+83%	$2.55	Q2 2024
31 Mar 2024	0%	+0%	$2,134,504	510,591	+42,134	+9%	$4.18	Q1 2024
31 Dec 2023	0%	+0%	$1,555,447	468,457	+3,770	+0.81%	$3.32	Q4 2023
30 Sep 2023	0%	+0%	$929,487	464,687	+21,188	+4.8%	$2.00	Q3 2023
30 Jun 2023	0%	+0%	$1,401,456	443,499	+22,322	+5.3%	$3.16	Q2 2023
31 Mar 2023	0%	+0%	$1,461,484	421,177	+11,448	+2.8%	$3.47	Q1 2023
31 Dec 2022	0%	+0%	$2,101,000	409,729	+25,732	+6.7%	$5.13	Q4 2022
30 Sep 2022	0%	+0%	$3,797,000	383,997	+100,705	+36%	$9.89	Q3 2022
30 Jun 2022	0%	+0%	$2,379,000	283,292	+15,387	+5.7%	$8.40	Q2 2022
31 Mar 2022	0%	+0%	$3,372,000	267,905	+52,581	+24%	$12.59	Q1 2022
31 Dec 2021	0%	+0%	$3,415,000	215,324	+10,633	+5.2%	$15.86	Q4 2021
30 Sep 2021	0%	+0%	$5,150,000	204,691	+166,023	+429%	$25.16	Q3 2021
30 Jun 2021	0%	+0%	$1,134,000	38,668	+38,668	NEW	$29.33	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.